High-density lipoprotein mimetics: promises and challenges

被引:27
作者
Sviridov, Dmitri [1 ]
Remaley, Alan T. [2 ]
机构
[1] Baker IDI Heart & Diabet Inst, Lab Lipoprot & Atherosclerosis, Melbourne, Vic 3004, Australia
[2] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
apolipoproteins; atherosclerosis; cholesterolmetabolism; lipoprotein metabolism; peptides; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; PEPTIDE; 4F; ANTIINFLAMMATORY PROPERTIES; CORONARY ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; AMPHIPATHIC PEPTIDES; PLASMA-CLEARANCE; LESION FORMATION; OXIDIZED LIPIDS;
D O I
10.1042/BJ20150832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concept of lipoprotein mimetics was developed and extensively tested in the last three decades. Most lipoprotein mimetics were designed to recreate one or several functions of high-density lipoprotein (HDL) in the context of cardiovascular disease; however, the application of this approach is much broader. Lipoprotein mimetics should not just be seen as a set of compounds aimed at replenishing a deficiency or dysfunctionality of individual elements of lipoprotein metabolism but rather as a designer concept with remarkable flexibility and numerous applications in medicine and biology. In the present review, we discuss the fundamental design principles used to create lipoprotein mimetics, mechanisms of their action, medical indications and efficacy in animal models and human studies.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [41] Inborn errors of high-density lipoprotein metabolism
    von Eckardstein, Arnold
    INTERNIST, 2019, 60 (12): : 1311 - 1317
  • [42] Latest Insights Into High-Density Lipoprotein Functions
    Noto, Hiroshi
    ENDOCRINOLOGIST, 2009, 19 (04) : 179 - 186
  • [43] High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities
    Zvintzou, Evangelia
    Xepapadaki, Eva
    Skroubis, George
    Mparnia, Victoria
    Giannatou, Katerina
    Benabdellah, Karim
    Kypreos, Kyriakos. E. E.
    PHARMACEUTICALS, 2023, 16 (06)
  • [44] High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis
    Meurs, Illiana
    Van Eck, Miranda
    Van Berkel, Theo J. C.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) : 1445 - 1467
  • [45] High-density lipoprotein-based nanoplatforms for macrophage-targeted diagnosis and therapy of atherosclerosis
    He, Jianhua
    Dai, Yingxuan
    Xu, Fengfei
    Huang, Xinya
    Gao, Yu
    Liu, Lisha
    Zhang, Wenli
    Liu, Jianping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [46] High-density lipoprotein-based drug discovery for treatment of atherosclerosis
    Du, Yu
    Wang, Li
    Hong, Bin
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (08) : 841 - 855
  • [47] Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
    Tardif, Jean-Claude
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 399 - 404
  • [48] Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein
    Bisoendial, RJ
    Hovingh, GK
    Levels, JHM
    Lerch, PG
    Andresen, I
    Hayden, MR
    Kastelein, JJP
    Stroes, ESG
    CIRCULATION, 2003, 107 (23) : 2944 - 2948
  • [49] High-density lipoprotein metabolism, composition, function, and deficiency
    Schaefer, Ernst J.
    Anthanont, Pimjai
    Asztalos, Bela F.
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (03) : 194 - 199
  • [50] Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
    Yamamoto, Suguru
    Yancey, Patricia G.
    Ikizler, Alp
    Jerome, W. Gray
    Kaseda, Ryohei
    Cox, Brian
    Bian, Aihua
    Shintani, Ayumi
    Fogo, Agnes B.
    Linton, MacRae F.
    Fazio, Sergio
    Kon, Valentina
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2372 - 2379